Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 01.21.2022
New augmented reality (AR) applications can make it easier to locate a chemical and biological (CB) threat by using real-time data, critical for warfighters on the “tactical edge”—an area where they may not be able to proceed safely and may be limited in communications connectivity. This technology is a new area of interest for the Defense Threat Reduction Agency’s (DTRA) Chemical and......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 01.21.2022
New Temporary Overcoat Solutions Improve Equipment Chemical Warfare Agent Resistance up to a Hundredfold Tests of newly developed temporary overcoats for tactical military equipment showed a reduction in the amount of absorbed chemical warfare agents (CWAs) by fivefold to a hundredfold, and the coatings remained effective beyond eight weeks in normal environmental conditions. Current......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 01.04.2022
Computational analysis is helping with rapid toxicology identification of chemical and biological threats. The Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense Program is developing predictive toxicology capabilities under the Computational Rapid......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 01.04.2022
Warfighters engaging with technology developers in scenario-driven exercises on a simulated battlefield provide vital information for industry and government partners to better bridge capability and usability gaps that can happen during research and development stages. The Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.27.2021
New studies that find equivalence between venous and finger-stick blood collection could improve diagnostic testing for warfighters in austere environments. Warfighters are often deployed to locations where they risk exposure to rare tropical diseases, emerging viral pathogens, or biological warfare agents. The ability to quickly diagnose an illness at the point of exposure and......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.27.2021
Nanosponge platform technology shows promise to effectively treat emerging infectious diseases such as COVID-19. Early testing indicates “nanosponges” may provide an innovative solution for treating COVID 19 and other emerging infectious diseases. The Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint Science and......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 09.30.2021
Targeting host proteins could defeat dangerous alphaviruses. Alphaviruses exist globally and are responsible for a considerable number of human and animal diseases. Infectious outbreaks can induce fever, malaise, and headaches, and severe infections can lead to encephalitis, long-term neurological abnormalities, and death....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 09.30.2021
Enzyme “resurrectors” offer a wider window to treat exposures to nerve agents. Medical countermeasures (MCMs) known as “resurrectors” may one day be incorporated into the combination antidote for nerve agents and organophosphate (OP) pesticides and could increase the currently small window of time to treat organophosphate nerve agent (OPNA) poisoning. The Defense Threat Reduction......
